from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/NzuZltS
This statement is saying that Pfizer, a pharmaceutical company, is forecasting a significant decrease in sales of its Covid-related products in 2023. As the global response to the pandemic evolves and more people are vaccinated, the demand for these products is likely to decrease, leading to a decline in sales for the company. This decrease in sales is expected to have a significant impact on Pfizer's overall revenue for 2023. However, it is important to note that the company may be able to offset this decline with sales in other areas of its business.
https://ift.tt/3HtxMK6
